Fund shareholders of CANbridge Pharmaceuticals Inc
ISIN KYG1821D1097 · United States
- Fund shareholders
- 1
- Of which ETFs
- 1 0 other funds
- Value held
- 115.2K $
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| iShares International Small-Cap Equity Factor ETF iShares Trust | 429,000 | 115.2K $ | 0.02 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares International Small-Cap Equity Factor ETF iShares Trust | 0.02 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 429,000 | -28.2 % |
| 2024Q2 | 1 | 0 | 597,481 | 0.0 % |
| 2024Q1 | 1 | -1 | 597,481 | -83.1 % |
| 2023Q4 | 2 | 3,538,481 |
Cite this page
Titelia. "Fund shareholders of CANbridge Pharmaceuticals Inc". https://titelia.com/en/stocks/canbridge-pharmaceuticals-inc-KYG1821D1097